tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IGXT Stock Latest News

IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process
Press ReleasesIntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process
3d ago
IGXT
IntelGenx Shows Promise in Alzheimer’s Study
PremiumCompany Announcements
IntelGenx Shows Promise in Alzheimer’s Study
19d ago
IGXT
IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
PremiumPress Releases
IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
19d ago
IGXT
IntelGenx Initiates Strategic Sale Process
PremiumCompany Announcements
IntelGenx Initiates Strategic Sale Process
1M ago
IGXT
IntelGenx announces initiation of sale and investment solicitation process
PremiumThe Fly
IntelGenx announces initiation of sale and investment solicitation process
1M ago
IGXT
IntelGenx Announces Initiation of the Sale and Investment Solicitation Process
PremiumPress ReleasesIntelGenx Announces Initiation of the Sale and Investment Solicitation Process
1M ago
IGXT
IntelGenx Begins Strategic Restructuring Efforts
PremiumCompany Announcements
IntelGenx Begins Strategic Restructuring Efforts
2M ago
IGXT
IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation Process
PremiumPress Releases
IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation Process
2M ago
IGXT
IntelGenx obtains court approval of sale, investment solicitation process
PremiumThe Fly
IntelGenx obtains court approval of sale, investment solicitation process
2M ago
ATAI
IGXT
IntelGenx Initiates Strategic Restructuring Process
PremiumCompany Announcements
IntelGenx Initiates Strategic Restructuring Process
2M ago
IGXT
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
PremiumPress Releases
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
2M ago
IGXT
IntelGenx Pursues Strategic Alternatives Amid Restructuring
PremiumCompany Announcements
IntelGenx Pursues Strategic Alternatives Amid Restructuring
2M ago
IGXT
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
PremiumPress ReleasesIntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
2M ago
IGXT
IntelGenx initiates restructuring proceedings under the CCAA
PremiumThe Fly
IntelGenx initiates restructuring proceedings under the CCAA
2M ago
IGXT
IntelGenx Shareholders Approve All Resolutions
PremiumCompany Announcements
IntelGenx Shareholders Approve All Resolutions
3M ago
IGXT
IntelGenx Announces Voting Results on Election of Directors
PremiumPress Releases
IntelGenx Announces Voting Results on Election of Directors
3M ago
IGXT
IntelGenx Trials Novel Parkinson’s Treatment
PremiumCompany Announcements
IntelGenx Trials Novel Parkinson’s Treatment
4M ago
IGXT
IntelGenx doses first patients in Phase 2 ‘MONTPARK’ trial
PremiumThe Fly
IntelGenx doses first patients in Phase 2 ‘MONTPARK’ trial
4M ago
IGXT
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
PremiumPress Releases
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
4M ago
IGXT
IntelGenx Faces FDA Hurdle for Pain Management Drug
PremiumCompany AnnouncementsIntelGenx Faces FDA Hurdle for Pain Management Drug
4M ago
IGXT
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
PremiumPress Releases
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
4M ago
IGXT
IntelGenx says Chemo Research receeives CRL on Buprenorphine Buccal Film ANDA
PremiumThe Fly
IntelGenx says Chemo Research receeives CRL on Buprenorphine Buccal Film ANDA
4M ago
IGXT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >